title: Evaluating technology under changing financing arrangements.
abstract: Changes in health care financing, such as Medicare prospective pricing and Medicaid capitated payment programs, have encouraged medical product industries to provide evidence of new technologies' cost-effectiveness. Health care providers have an equal responsibility to determine the validity of that research.
mesh_terms: D003362:Cost-Benefit Analysis; D004345:Drug Industry; D007221:Industry; D012952:Societies; D013673:Technology Assessment, Biomedical / Q000191:economics*; D014481:United States